| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/15/2008 | US7319143 Genetically-engineered MHC molecules |
| 01/15/2008 | US7319138 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/15/2008 | CA2132740C Pharmaceutical composition containing cyclosporin derivative |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004536A1 Toxin detection method |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008003978A2 Dioxo-alkanes and dioxo-alkenes |
| 01/10/2008 | WO2008003748A2 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 01/10/2008 | WO2008003130A1 A method and composition for treating the scalp |
| 01/10/2008 | WO2007135466A3 Substituted n-acyl homoserine lactones |
| 01/10/2008 | WO2007109686A3 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 01/10/2008 | US20080010694 Method of acquiring immunological tolerance |
| 01/10/2008 | US20080009519 Method of modulating t cell functioning |
| 01/10/2008 | US20080009514 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | US20080009508 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin |
| 01/10/2008 | US20080009476 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009442 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis |
| 01/10/2008 | US20080009416 Thiazolium compounds and uses thereof |
| 01/10/2008 | US20080009014 Receptor activator of NF-kappaB |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/10/2008 | CA2660182A1 Dioxo-alkanes and dioxo-alkenes compounds |
| 01/10/2008 | CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use |
| 01/10/2008 | CA2656756A1 Toxin detection method |
| 01/10/2008 | CA2656087A1 Sugar-free storage-stable antihistaminic syrups |
| 01/10/2008 | CA2652058A1 Compositions and methods for modulating immune responses |
| 01/09/2008 | EP1876184A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
| 01/09/2008 | EP1875907A2 Use of yessotoxins in the treatment of allergic and asthmatic processes |
| 01/09/2008 | EP1875906A2 Therapeutic use of yessotoxins as human tumor cell growth inhibitors |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874806A2 Vaccine against burkholderia infections |
| 01/09/2008 | EP1874788A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| 01/09/2008 | EP1874772A1 Purine and imidazopyridine derivatives for immunosuppression |
| 01/09/2008 | EP1874734A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874348A1 Immunomodulating compositions and uses therefor |
| 01/09/2008 | EP1874343A2 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| 01/09/2008 | EP1874294A1 Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions |
| 01/09/2008 | EP1874270A2 Pharmaceutical aerosol composition |
| 01/09/2008 | EP1666050A4 Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1400513B1 Unsymmetrical cyclic diamine compound |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1135463B1 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 01/09/2008 | EP0988042B1 Combination of product r and an antiviral agent in the therapy of hiv infections |
| 01/09/2008 | EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | CN101103044A Anti-alhpha 9 integrin antibody and the use thereof |
| 01/09/2008 | CN101103043A Kir-binding agents and methods of use thereof |
| 01/09/2008 | CN101102788A Fibrosis inhibitor for implanted organ |
| 01/09/2008 | CN101100483A Analogue of muramyl dipeptide |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101099832A Traditional Chinese medicinal compound for treating urticaria |
| 01/09/2008 | CN101099798A Life prolonging health care product and its preparation method |
| 01/09/2008 | CN101099749A Composition containing lactobacillus acidophilus and bidifobacterium longum and application thereof |
| 01/09/2008 | CN101099571A Health-care food for strengthening immunity and its preparing method |
| 01/09/2008 | CN100360940C Method and apparatus for screening G protein coupled receptor medicine |
| 01/09/2008 | CN100360658C Enteral microecological formulation and its preparation process |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360500C N,N'-biacetylcysteine-diarginine salt isomer and its uses |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360175C Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 01/09/2008 | CN100360132C Combination of medication for antivirus in use for eye region and preparation method |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/09/2008 | CN100360124C Use of 2-amino-2(2-(4-octyl phenyl)ethyl)-1,3-propylene glycol in the preparation of medicaments of preventing and curing immune liver injury |
| 01/09/2008 | CN100360123C Methods and pharmaceutical compostions employing desmethylselegiline |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |
| 01/08/2008 | US7317090 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal |
| 01/08/2008 | US7317089 Immunmoglobulin specific to tumor necrosis factor (ligand) superfamily, member 13b (tnfsf13b) protein for use in treatment and prevention of autoimmune, inflammatory, respiratory system, skin , blood and cell proliferative disorders |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317085 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 01/08/2008 | US7317077 Neural thread proteins (NTP); antiproliferative agents |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7316997 GH secretagogues and uses thereof |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2389170C A process for the production of epinastine hydrochloride in the high-melting crystal modification |
| 01/08/2008 | CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 01/08/2008 | CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 01/03/2008 | WO2008002449A2 Glycomimetic inhibitors of siglec-8 |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |